The Serum Institute of India (SII) has prepared 4 million doses of the new coronavirus vaccine. “IBS has already manufactured 40 million doses of the vaccine, under DCGI’s manufacturing and storage at risk license,” the company said in a statement. The SII, with the help of the Indian Council of …
Read More »
The Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, and the Indian Council of Medical Research (ICMR), India’s leading body for biomedical research, today announced the completion of trial enrollment Phase 3 clinical trials for Covishield or Oxford covid vaccine in India. Covishield has been developed …
Read More »
NEW DELHI: India may also consider continued reviews for the Covid-19 vaccine, particularly the Oxford-AstraZeneca-developed candidate that is already under accelerated review by the UK health regulator, to further accelerate the approval of vaccines in the current pandemic situation. An ongoing review will allow the regulator to examine the data …
Read More »
The Serum Institute is targeting, initially, 100 million doses of the Oxford vaccine. Highlight The coronavirus vaccine could be ready in December: Adar Poonawalla Serum Institute targets 100 million doses of Oxford vaccine at first More than 150 potential vaccines are being developed and tested globally New Delhi: The Oxford …
Read More »
Serum Institute of India Executive Director Adar Poonawalla on Monday expressed “some preliminary good news” about the efficacy of early covid vaccines, particularly the Oxford candidate vaccine developed by the University of Oxford with AstraZeneca Plc after an article de Bloomberg published that the Oxford covid vaccine “has produced a …
Read More »
Covaxin, a candidate vaccine developed indigenously by Bharat Biotech, obtained authorization for the phase three trial in India. A leading source said that rehearsals will begin in the first week of November. The source further said that 18-19 sites have been selected for the trial and more than 22,000 volunteers …
Read More »
NEW DELHI: The Serum Institute of India and Bharat Biotech are expected to conduct advanced stage clinical trials of intranasal Covid-19 vaccines in the coming months once they receive regulatory approval, Union Health Minister Harsh said on Sunday Vardhan. Vardhan said the late-stage trial typically involves thousands of participants, sometimes …
Read More »
Union Health Minister Harsh Vardhan said Sunday the government is reflecting on plans to roll out the country’s first Covid-19 vaccine by prioritizing target groups across the population. He clarified that covid vaccine supplies are anticipated to be available in limited quantities at first. “In a huge country like India, …
Read More »
NEW DELHI: The government plans to administer around 40-50 crore of covid-19 vaccines to 20-25 crore of Indians in July. The Center, together with the states, is also preparing a list of priority population groups, especially front-line health workers, who would receive vaccines, Union Health Minister Harsh Vardhan said on …
Read More »
The survey results show that a sizeable population remains vulnerable and susceptible to the coronavirus. It was estimated that one in 15 people aged 10 years and older was exposed to SARS-CoV2 in August 2020, showing that a sizeable population is still susceptible to COVID-19, according to the second sero-survey …
Read More »